CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Heilongjiang ZBD Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Heilongjiang ZBD Pharmaceutical Co Ltd
No. 8
Yantai First Road, Pingfang District
Phone: +86 45186811969p:+86 45186811969 HAERBIN, HNG  150060  China Ticker: 603567603567
Business Summary
HeiLongJiang ZBD Pharmaceutical Co Ltd is a China-based company engaged in the research, development, production and sale of pharmaceuticals. The primary products include active pharmaceutical ingredients, chemical preparations, traditional Chinese medicine preparations and biologics, primarily for cardiovascular, antiviral, respiratory, pediatric and traditional Chinese medicine applications. The Company is also engaged in pharmaceutical and traditional Chinese medicine trading. The Company mainly conducts its businesses in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202512/31/2024Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board TonghuaFang 62 12/21/2019 3/1/2011
Chief Financial Officer LeiWang 44 4/19/2023 9/1/2019
General Manager, Director JiujiangYan 47 6/30/2022 8/1/2019
7 additional Officers and Directors records available in full report.

General Information
Number of Employees: 2,349 (As of 12/31/2024)
Outstanding Shares: 940,996,515 (As of 7/29/2025)
Shareholders: 23,701
Stock Exchange: SHA
Fax Number: +86 45187105767


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, September 9, 2025
Register now for our FAST Rating webinar on September 10 at 2:00 PM ET!